Background: Vertebroplasty is a procedure most commonly used for vertebral compression fractures. Although it is a relatively safe procedure, complications have been reported. Cement embolism is seen in 2.1%-26% of patients after percutaneous vertebroplasty. Case presentation: a 38-year-old male who was diagnosed with cushing's syndrome, underwent percutaneous vertebroplasty for his thoracic osteoporotic compression fractures. 24-hours following vertebroplasty, he presented to emergency department with acute-onset dyspnea and chest pain. Chest radiography showed an opaque linear lesion in left pulmonary artery which was suggestive of cement embolism. Pulmonary spiral CT-scan further confirmed the diagnosis. The patient's symptoms improved over time, and warfarin was started with close cardiopulmonary assessments for indicators of cement embolus removal. Conclusion: in patients with pulmonary cement embolism, conservative treatment may be recommended rather than a surgical removal except when the obstruction is extensive enough to cause hemodynamic changes. Given that all the related studies have suggested that pulmonary thromboembolism can occur as a complication due to bone cement leakage, discovering new cement alternatives and/or injection devices, seems beneficial.
Background
Vertebroplasty is a minimally invasive procedure most commonly used for vertebral compression fractures which was first introduced by Galibert et al., in 1987 [1] . In this procedure, polymethylmethacrylate (PMMA) is injected directly into the vertebral body through its pedicle, to restore the height partially, stabilize bony trabeculae, and alleviate pain. Due to its minimal invasion and immediate pain relief, percutaneous vertebroplasty gained popularity for the treatment of painful tumor infiltration disease such as multiple myeloma [2] , and metastatic carcinoma [3] [4] [5] , and for patients who have refractory pain due to osteoporotic thoracolumbar compression fractures [6] [7] [8] Although it is a relatively safe procedure, complications have been reported [9, 10] . Acrylic cement of polymethylmethacrylate injected into the vertebral body can leak into the paravertebral venous system and reach the pulmonary artery via the azygos vein leading to a cement pulmonary embolism [11] [12] [13] [14] [15] . Pulmonary embolism of cement is seen in 4.6% of patients after percutaneous vertebroplasty. It can be asymptomatic and is directly related to the frequency of paravertebral venous leak, but not to the number of vertebral bodies treated [16] . Here, we report a case of cement pulmonary embolism following vertebroplasty for thoracic compression fracture.
Case report
This is a 38-year-old smoker male who is a truck driver. He visited his family physician in July 2017, because of unintentional weight gain and a debilitating back pain. In physical examination he had a buffalo hump and central obesity, thus he was prescribed symptomatic treatment for his back pain and referred to an endocrinologist to evaluate for cushing's syndrome. His laboratory studies in following month showed a significantly high level of 24-h urinary free cortisol which was repeated 3 times and a plasma ACTH of 82pg/ml, which was suggestive of an ACTH-dependent cushing's syndrome. The urinary free cortisol after low and high-dose dexamethasone suppression test reported to be 546 and 764 mcg/24h respectively, which means resistance to dexamethasone and a negative test result. A magnetic resonance image (MRI) of pituitary following gadolinium administration was done which showed no abnormality. Because of the discordance between pituitary MRI, plasma ACTH level, and high-dose dexamethasone suppression https://doi.org/10.1016/j.rmcr.2018.06.009 test results, inferior petrosal sinus sampling (IPSS) was done by interventional radiologist, which showed a petrosal/peripheral ACTH ratio of less than 2. An ectopic ACTH syndrome was suggested which could not be localized with chest and abdominal CT scan. Ketoconazole was administered to control the cortisol excess, while planning for a bilateral adrenalectomy. The patient was also evaluated for his refractoy back pain. MRI revealed diffuse osteopenic signal changes in lumbar vertebrae and multiple sites of compression fracture in all thoracolumbar vertebral bodies. Bone densitometry showed osteoporosis most severe at spine (mean Z-score and T-score < −2.9). As the patient was symptomatic, the decision has been made to proceed with vertebroplasty. High viscosity cement was injected into T7 to T12 vertebral bodies under fluoroscopic guidance in February 2018. The total volume of injected cement was 4 cc in each level. The patient tolerated the procedure and was discharged uneventfully. 24-hours following his vertebroplasty, he presented to our emergency department with a history of sudden-onset dyspnea and chest pain. Vital signs were within normal limits except tachycardia. He had no hypoxia, fever, chills, cough, and hemoptysis. The ECG was normal, except sinus tachycardia and cardiac troponins were negative. Echocardiography revealed no regional wall motion abnormalities with a 50% ejection fraction, a tricuspid valve regurgitation, and mildly increased systolic pulmonary artery pressure (35 mmHg). Chest radiography showed an opaque linear lesion in the left pulmonary artery ( Fig. 1 ), which raised the suspicion of bone cement pulmonary embolism. Parenteral anticoagulation was started, and patient underwent pulmonary spiral CTscan which revealed artifact-like hyperdense area in main pulmonary artery and left pulmonary artery suggestive of cement embolism (Figs. 2 and 3). During the hospitalization, patient's symptoms resolved, and warfarin was started. Cardiovascular surgery consultants recommended medical rather than surgical treatment with close cardiopulmonary monitoring for any signs and symptoms suggestive of worsening embolism. The patient was asymptomatic when he was discharged. Serial cardiac and pulmonary assessments will be carried out looking for increased pulmonary artery pressure as an indicator for the removal of the cement embolus.
Discussion
We present a case of 38-year-old man who underwent a T7 to T12 vertebroplasty because of osteoporotic compression fractures, and subsequently had a pulmonary cement embolization to his pulmonary arterial circulation, which was treated non-operatively with anticoagulation.
Operative treatment of vertebral compression fractures has included percutaneous vertebroplasty for the past 30 years. Introduced by Galibert et al. [1] in 1987, this procedure gained popularity steadily and is used as an immediate pain relief method, in osteoporotic compression fractures [6] [7] [8] and for treatment of tumor infiltration disease such as metastatic carcinoma [3] [4] [5] , and multiple myeloma [2] . Efficacy of vertebroplasty in alleviating pain, is not without controversy according to Buchbinder et al. [17] and Kallmes et al. [18] studies, which showed no improvement in pain and pain-related disability in osteoporotic spinal fractures. Bone cement leakage is of particular concern. Cement leakage into the spinal canal can lead to canal stenosis and cord compression [19, 20] , and cement leakage into the intervertebral foramina can cause nerve root compression [21] . Additionally, cement leakage into the perivertebral system and inferior vena cava (IVC) can drift toward the right heart and pulmonary arterial system with catastrophic results such as cardiopulmonary arrest [33, 34] , acute kidney injury [22] , paradoxical embolism through a patent foramen ovale [23] , and death [10, 24, 36] . Arterial embolization to the aorta and anterior spinal artery has also been described [25, 26] . The risk of cement pulmonary embolism first reported by Padovani et al. [27] exists with both vertebroplasty and kyphoplasty, but the exact rate is uncertain because the patients are not routinely screened for cement embolism [28] . The incidences of pulmonary cement embolism after vertebroplasty ranges from 2.1% to 26%, with much of this variation resulting from which imaging technique is used and whether the study is prospective or retrospective [16, [29] [30] [31] [32] . Clinical features of cardiopulmonary side effects of cement leak in percutaneous vertebroplasty and kyphoplasty include precordial chest pain and tightness [33] [34] [35] [36] , dyspnea [35] [36] [37] [38] , cyanosis, palpitation [34] , acute respiratory distress syndrome (ARDS) Table 1 Published case reports of pulmonary/cardiac cement embolism (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) (2016) (2017) [69] (continued on next page) [98] (continued on next page) [13] M = male, F = female, PCE = pulmonary cement embolism, ARDS = acute respiratory distress syndrome, PVP = percutaneous vertebroplasty. [39, 40] , and cardiac arrest [12] , although some patients with pulmonary cement embolism are asymptomatic [41] [42] [43] [44] . The symptoms of cement embolism occurs more commonly days to months after, rather than during the procedure [12, 24, 39, 45] . The cement used in vertebroplasty is of such high density compared to lung field that the visualization of cement emboli on CXR is quite striking, but multiple dense opacities with a branching shape which are scattered randomly or diffusely throughout the lungs are more common [16, 29, 44] . In our patient, CXR showed an opaque linear lesion in the left pulmonary artery without significant scattered lesions in the lungs. Echocardiography is a safe and non-invasive modality to evaluate hemodynamic status and to reveal the probable echogenic material in the cardiac chambers [46, 47] . Chest CT scan accurately shows the locations, the lengths, and the number of cement emboli [35] . Abdul-Jalil et al. proposed that PMMA has a prothrombotic property and can cause endothelial injury, which can result in additional thrombosis [48] . The formation of PMMA toxins can cause direct cellular injury by increasing membrane permeability through releasing inflammatory mediators, and superoxide production. Pulmonary cement embolism finally shares similar phathophysiological similarities with pulmonary embolisms [40] .
The cornerstone of treatment of pulmonary cement embolism is close cardiopulmonary monitoring and anticoagulation [27, [49] [50] [51] [52] [53] but there are some reports of cement embolism requiring surgical removal (including cardiopulmonary bypass and arteriotomy) [33, [35] [36] [37] [38] [39] [54] [55] [56] . Choe et al. proposed that asymptomatic pulmonary cement emboli should not alter medical treatment [16] . In Venman's study, all 11 patients with venous PMMA migration remained asymptomatic during 1-year follow up [31] . Krueger et al. proposed a management algorithm that includes conservative approach for peripheral asymptomatic cases, anticoagulation for the symptomatic peripheral and asymptomatic central emboli, and surgical treatment for symptomatic central embolism only [57] . We selected anticoagulation and close monitoring for our patient regarding the published case reports of cement embolism which is summarized in Table 1 . Because of nondegradable and toxic properties of PMMA, attempts have been made to explore alternative materials that are more suitable for vertebroplasty and kyphoplasty [58] [59] [60] .
Conclusion
In patients with pulmonary cement embolism, conservative treatment may be recommended rather than a surgical removal except when the obstruction is extensive enough to cause hemodynamic changes. Given that all the related studies have suggested that pulmonary thromboembolism can occur as a complication due to bone cement leakage, discovering new cement alternatives and/or injection devices, seems beneficial.
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